[1] CHEN X, WANG Z, DUAN N, et al. Osteoblast-osteoclast interactions. Connect Tissue Res. 2018;59(2):99-107.
[2] OZAKI D, KUBOTA R, MAENO T, et al. Association between gut microbiota, bone metabolism, and fracture risk in postmenopausal Japanese women. Osteoporos Int. 2021;32(1):145-156.
[3] CIPRIANI C, COLANGELO L, SANTORI R, et al. The Interplay Between Bone and Glucose Metabolism. Front Endocrinol (Lausanne). 2020;11:122.
[4] ZHAO X, CUI P, HU G, et al. PIP5k1beta controls bone homeostasis through modulating both osteoclast and osteoblast differentiation. J Mol Cell Biol. 2020; 12(1):55-70.
[5] REPPE S, LIEN TG, HSU YH, et al. Distinct DNA methylation profiles in bone and blood of osteoporotic and healthy postmenopausal women. Epigenetics. 2017; 12(8):674-687.
[6] CHEN X, HUA W, HUANG X, et al. Regulatory Role of RNA N(6)-Methyladenosine Modification in Bone Biology and Osteoporosis. Front Endocrinol (Lausanne). 2019;10:911.
[7] TRAUBE FR, CARELL T. The chemistries and consequences of DNA and RNA methylation and demethylation. RNA Biol. 2017;14(9):1099-1107.
[8] GUTBROD MJ, MARTIENSSEN RA. Conserved chromosomal functions of RNA interference. Nat Rev Genet. 2020;21(5):311-331.
[9] ZHAO BS, ROUNDTREE IA, HE C. Post-transcriptional gene regulation by mRNA modifications. Nat Rev Mol Cell Biol. 2017;18(1):31-42.
[10] YU S, LI X, LIU S, et al. N(6)-Methyladenosine: A Novel RNA Imprint in Human Cancer. Front Oncol. 2019;9:1407.
[11] DESROSIERS R, FRIDERICI K, ROTTMAN F. Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells. Proc Natl Acad Sci U S A. 1974; 71(10):3971-3975.
[12] Fu Y, Dominissini D, Rechavi G, et al. Gene expression regulation mediated through reversible m(6)A RNA methylation. Nat Rev Genet. 2014;15(5):293-306.
[13] YANG Y, HSU PJ, CHEN YS, et al. Dynamic transcriptomic m(6)A decoration: writers, erasers, readers and functions in RNA metabolism. Cell Res.2018;28(6):616-624.
[14] DENG X, SU R, WENG H, et al. RNA N(6)-methyladenosine modification in cancers: current status and perspectives. Cell Res. 2018;28(5):507-517.
[15] ZHANG Y, GU X, LI D, et al. METTL3 Regulates Osteoblast Differentiation and Inflammatory Response via Smad Signaling and MAPK Signaling. Int J Mol Sci. 2019;21(1):199.
[16] 黎琮南, 李毅成, 杨渊. m6A RNA甲基化在骨骼疾病中的作用[J]. 中国生物化学与分子生物学报,2020,36(11):1303-1311.
[17] YU J, SHEN L, LIU Y, et al. The m6A methyltransferase METTL3 cooperates with demethylase ALKBH5 to regulate osteogenic differentiation through NF-kappaB signaling. Mol Cell Biochem. 2020;463(1-2):203-210.
[18] 陈伟坚, 张罡瑜, 林天烨, 等. RNA m~6A甲基化修饰参与及调控骨科相关疾病[J]. 中国组织工程研究,2021,25(26):4236-4242.
[19] TIAN C, HUANG Y, LI Q, et al. Mettl3 Regulates Osteogenic Differentiation and Alternative Splicing of Vegfa in Bone Marrow Mesenchymal Stem Cells. Int J Mol Sci. 2019;20(3):551.
[20] 谭素明. 墨旱莲通过Mettl3/14介导m6A动态修饰调控骨髓间充质干细胞成骨分化的作用机制研究[D]. 大连:大连医科大学,2021.
[21] YAN G, YUAN Y, HE M, et al. m(6)A Methylation of Precursor-miR-320/RUNX2 Controls Osteogenic Potential of Bone Marrow-Derived Mesenchymal Stem Cells. Mol Ther Nucleic Acids. 2020;19:421-436.
[22] ALARCON C R, GOODARZI H, LEE H, et al. HNRNPA2B1 Is a Mediator of m(6)A-Dependent Nuclear RNA Processing Events. Cell. 2015;162(6):1299-1308.
[23] WU Y, XIE L, WANG M, et al. Mettl3-mediated m(6)A RNA methylation regulates the fate of bone marrow mesenchymal stem cells and osteoporosis. Nat Commun. 2018;9(1):4772.
[24] YAO Y, BI Z, WU R, et al. METTL3 inhibits BMSC adipogenic differentiation by targeting the JAK1/STAT5/C/EBPbeta pathway via an m(6)A-YTHDF2-dependent manner. FASEB J. 2019;33(6):7529-7544.
[25] KIM T, HA H I, KIM N, et al. Adrm1 interacts with Atp6v0d2 and regulates osteoclast differentiation. Biochem Biophys Res Commun. 2009;390(3):585-590.
[26] LI D, CAI L, MENG R, et al. METTL3 Modulates Osteoclast Differentiation and Function by Controlling RNA Stability and Nuclear Export.Int J Mol Sci. 2020;21(5):1660.
[27] WANG W, QIAO S C, WU XB, et al. Circ_0008542 in osteoblast exosomes promotes osteoclast-induced bone resorption through m6A methylation. Cell Death Dis. 2021;12(7):628.
[28] MO XB, ZHANG Y H, LEI SF. Genome-wide identification of m(6)A-associated SNPs as potential functional variants for bone mineral density. Osteoporos Int. 2018;29(9):2029-2039.
[29] MI B, XIONG Y, YAN C, et al. Methyltransferase-like 3-mediated N6-methyladenosine modification of miR-7212-5p drives osteoblast differentiation and fracture healing. J Cell Mol Med. 2020;24(11):6385-6396.
[30] 骆帝, 许波, 李刚, 等. 骨碎补治疗骨关节炎的网络药理学研究[J]. 中草药, 2018,49(15):3516-3522.
[31] Cui Z, Crane J, Xie H, et al. Halofuginone attenuates osteoarthritis by inhibition of TGF-beta activity and H-type vessel formation in subchondral bone. Ann Rheum Dis. 2016;75(9):1714-1721.
[32] Shen J, Abu-Amer Y, O’Keefe R J, et al. Inflammation and epigenetic regulation in osteoarthritis. Connect Tissue Res. 2017;58(1):49-63.
[33] Liu Q, Li M, Jiang L, et al. METTL3 promotes experimental osteoarthritis development by regulating inflammatory response and apoptosis in chondrocyte. Biochem Biophys Res Commun. 2019;516(1):22-27.
[34] 黄媚. METTL3在机械牵张促进BMSC成骨分化中的作用研究[D]. 上海:上海体育学院,2021.
[35] 李露. 基于m6A甲基化探讨清热活血方治疗活动期RA的作用机制[D]. 北京:中国中医科学院,2021.
|